Form 4: Hims & Hers CLO Reports Routine Stock Transactions

Hims & Hers Health's Chief Legal Officer, Soleil Boughton, reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported transactions on September 15, 2025.
• These transactions included the acquisition of 41,420 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Concurrently, 22,829 shares of Class A Common Stock were disposed of at a price of $53.96 per share to cover tax withholding obligations related to the RSU vesting.
• Following these reported transactions, Ms. Boughton's direct beneficial ownership of Class A Common Stock is 169,041 shares.
• Several tranches of derivative Restricted Stock Units also vested, converting to Class A Common Stock, with remaining beneficial ownership of RSUs detailed across different vesting schedules.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine insider transaction (RSU vesting and tax-related sale) that does not indicate any new positive or negative developments for the company's operations or financial health.

Positives

• The vesting of 41,420 Restricted Stock Units indicates continued executive compensation and retention, aligning management interests with shareholder value.
• The transactions are part of a pre-arranged plan (Rule 10b5-1(c)), suggesting a systematic approach to equity management rather than discretionary selling.

Negatives

• The disposition of 22,829 shares, valued at $53.96 per share, represents a reduction in the Chief Legal Officer's direct equity stake, although it was for tax withholding purposes.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider's equity transactions.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transactions and does not provide information relevant to broader industry trends or competitive landscape analysis. Such filings are standard practice for publicly traded companies.

Stakeholder Impact

• Shareholders: The transaction is a routine insider equity movement and is unlikely to have a significant direct impact on the company's stock price or long-term value. It reflects standard executive compensation practices.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Future quarterly vesting installments of the reported Restricted Stock Units will continue as per their respective 4-year service-based vesting schedules.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions involving the vesting of Restricted Stock Units and the sale of shares for tax purposes, executed under a Rule 10b5-1 plan. Such transactions are common and do not provide new fundamental information about the company's operational performance, financial outlook, or strategic direction. Therefore, it does not warrant a change in investment recommendation, and a 'hold' stance is maintained based solely on this filing.

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Disposition, Tax Withholding